BEIGENE, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103.6 HKD | +1.67% |
|
+3.70% | -5.90% |
| 05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
| 05-09 | Beigene Q1 Loss Shrinks as Revenue Grows; Company's Shares Nearly 7% Up | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BEIGENE, LTD. | Bio Therapeutic Drugs | +1.67% | +3.70% | -5.90% | -25.20% | +26.81% | 18.08B | - | - | - |
- Stock Market
- Equities
- BGNE Stock
- 6160 Stock
- Charts BeiGene, Ltd.
- Relative Strength Chart
